INmune Bio Q4 EPS $(0.47) Misses $(0.44) Estimate, Sales $28.00K Miss $40.00K Estimate

INmune Bio Inc. -7.00%

INmune Bio Inc.

INMB

7.70

-7.00%

INmune Bio (NASDAQ: INMB) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.44) by 6.82 percent. This is a 46.87 percent decrease over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $28.00 thousand which missed the analyst consensus estimate of $40.00 thousand by 30.00 percent. This is a 71.13 percent decrease over sales of $97.00 thousand the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via